Cargando…

New-onset giant cell arteritis following COVID-19 mRNA (BioNTech/Pfizer) vaccine: a double-edged sword?

Detalles Bibliográficos
Autores principales: Anzola, Ana M., Trives, Laura, Martínez-Barrio, Julia, Pinilla, Blanca, Álvaro-Gracia, José María, Molina-Collada, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810207/
https://www.ncbi.nlm.nih.gov/pubmed/35112193
http://dx.doi.org/10.1007/s10067-021-06041-7
_version_ 1784644202509893632
author Anzola, Ana M.
Trives, Laura
Martínez-Barrio, Julia
Pinilla, Blanca
Álvaro-Gracia, José María
Molina-Collada, Juan
author_facet Anzola, Ana M.
Trives, Laura
Martínez-Barrio, Julia
Pinilla, Blanca
Álvaro-Gracia, José María
Molina-Collada, Juan
author_sort Anzola, Ana M.
collection PubMed
description
format Online
Article
Text
id pubmed-8810207
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-88102072022-02-03 New-onset giant cell arteritis following COVID-19 mRNA (BioNTech/Pfizer) vaccine: a double-edged sword? Anzola, Ana M. Trives, Laura Martínez-Barrio, Julia Pinilla, Blanca Álvaro-Gracia, José María Molina-Collada, Juan Clin Rheumatol Letter to the Editor Springer International Publishing 2022-02-03 2022 /pmc/articles/PMC8810207/ /pubmed/35112193 http://dx.doi.org/10.1007/s10067-021-06041-7 Text en © International League of Associations for Rheumatology (ILAR) 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Letter to the Editor
Anzola, Ana M.
Trives, Laura
Martínez-Barrio, Julia
Pinilla, Blanca
Álvaro-Gracia, José María
Molina-Collada, Juan
New-onset giant cell arteritis following COVID-19 mRNA (BioNTech/Pfizer) vaccine: a double-edged sword?
title New-onset giant cell arteritis following COVID-19 mRNA (BioNTech/Pfizer) vaccine: a double-edged sword?
title_full New-onset giant cell arteritis following COVID-19 mRNA (BioNTech/Pfizer) vaccine: a double-edged sword?
title_fullStr New-onset giant cell arteritis following COVID-19 mRNA (BioNTech/Pfizer) vaccine: a double-edged sword?
title_full_unstemmed New-onset giant cell arteritis following COVID-19 mRNA (BioNTech/Pfizer) vaccine: a double-edged sword?
title_short New-onset giant cell arteritis following COVID-19 mRNA (BioNTech/Pfizer) vaccine: a double-edged sword?
title_sort new-onset giant cell arteritis following covid-19 mrna (biontech/pfizer) vaccine: a double-edged sword?
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810207/
https://www.ncbi.nlm.nih.gov/pubmed/35112193
http://dx.doi.org/10.1007/s10067-021-06041-7
work_keys_str_mv AT anzolaanam newonsetgiantcellarteritisfollowingcovid19mrnabiontechpfizervaccineadoubleedgedsword
AT triveslaura newonsetgiantcellarteritisfollowingcovid19mrnabiontechpfizervaccineadoubleedgedsword
AT martinezbarriojulia newonsetgiantcellarteritisfollowingcovid19mrnabiontechpfizervaccineadoubleedgedsword
AT pinillablanca newonsetgiantcellarteritisfollowingcovid19mrnabiontechpfizervaccineadoubleedgedsword
AT alvarograciajosemaria newonsetgiantcellarteritisfollowingcovid19mrnabiontechpfizervaccineadoubleedgedsword
AT molinacolladajuan newonsetgiantcellarteritisfollowingcovid19mrnabiontechpfizervaccineadoubleedgedsword